News

Industries

Companies

Jobs

Events

People

Video

Audio

Galleries

Submit content

My Account

Advertise with us

SA hasn’t built a menopause policy yet. A chance to get it right first time

South African workplaces are only just starting to talk about menopause. A Medihelp executive argued in a recent Bizcommunity op-ed that local companies can no longer afford to ignore it, and Discovery Health launched a dedicated menopause support app for its members earlier this year. Both are genuine signs the conversation is starting.
Image credit:  on
Image credit: Elisa Ventur on Unsplash

Neither amounts to an established policy.

Compare that to the United Kingdom, where menopause action plans become mandatory for large employers from around 2027, and where “menopause-friendly employer” accreditation already exists.

South Africa doesn’t have a menopause policy problem to fix yet. It has the rarer opportunity to build one from scratch.

That’s worth using well.

Everywhere this conversation matured earlier, the UK and the US especially, it got built around one window: the visible, symptomatic years of perimenopause and menopause.

That window runs at most a decade.

What it consistently leaves out is postmenopause, the phase that starts once that decade ends and lasts for the rest of a woman’s life, on average another 30 to 40 years.

South Africa can design its version around that longer phase from day one, instead of retrofitting it in later the way other countries now have to.

The numbers behind the imbalance

Perimenopause, the phase currently getting most of the attention, runs four to 10 years.

Menopause itself isn’t a duration; it’s a single point, confirmed after 12 months without a period, typically around age 51.

Postmenopause starts there and continues for the rest of a woman’s life, on average 30 to 40 years, several times longer than perimenopause and menopause combined.

A policy built around “getting a woman through menopause” covers, at most, a decade.

It has nothing to say about the three or four decades after, precisely the decades during which many women hold their most senior, hardest-to-replace roles.

Why this is a retention question, not only a health one

South Africa doesn’t yet have its own data on the cost, but the pattern is well documented elsewhere.

In the United States, the Mayo Clinic estimates menopause-related productivity losses cost employers around $1.8bn annually in missed workdays alone, with related healthcare costs exceeding $24bn a year.

In the United Kingdom, government reporting cites 14 million working days lost annually to menopause, equivalent to £1.88bn in lost productivity, and separate research puts the cost of replacing a single senior employee at 50% to 200% of their annual salary once recruitment, onboarding and lost expertise are counted.

Those figures measure the shorter window of perimenopause and menopause.

Women aged 45 to 55 are already one of the fastest-growing senior demographics in most organisations, and that age bracket is entering postmenopause, not leaving it.

A policy that treats a woman’s needs as resolved once she passes the 12-month menopause mark is withdrawing support at the exact point many of these women move into their most senior years, the years a business can least afford to get wrong.

South Africa doesn’t need to fix a menopause policy that only covers the getting-through phase. It hasn’t built one yet, which means it can build the right one first.

What actually continues for the next 30 years

Postmenopause is not a symptom-free plateau, and each part of it carries a workplace cost most policies never connect back to it.

Bone density loss continues quietly for decades, raising fracture risk for senior staff who are often still travelling and doing physically demanding site or client visits.

It also reshapes facial bone structure in ways colleagues typically read as ordinary ageing rather than a treatable hormonal process, quietly affecting how a woman’s authority gets perceived in the room.

Cardiovascular risk keeps rising through this phase rather than levelling off, which is exactly the risk an annual wellness check built around the shorter symptom window won’t catch.

Vaginal and urinary symptoms often persist or worsen rather than fade, showing up as unexplained sick leave and discomfort during long meetings or travel that nobody names out loud.

Skin, cognitive and metabolic health all keep responding to the same permanent hormonal shift long after perimenopause’s visible symptoms have gone quiet.

The cognitive piece does the most damage in a boardroom: a senior leader who seems a step slower under pressure than she used to be gets read as declining, not as managing a normal, decades-long biological process.

None of this arrives as a single dramatic event the way a hot flush in a meeting might.

It arrives as a slow accumulation of small, misread signals: more sick days than expected, a leader who seems less resilient than she used to be, someone quietly stepping back from a stretch assignment or a promotion conversation.

Read without context, that pattern looks like a performance problem. It isn’t one.

Building the longer policy, not the shorter one

This doesn’t call for an elaborate HR programme. It calls for designing the conversation around the phase that actually lasts, before habit sets in around the shorter, more visible one instead.

A South African approach built around postmenopause would include manager awareness that support doesn’t end at the 12-month mark, healthcare benefits that cover long-term monitoring, bone density and cardiovascular screening, not only acute symptom management, and a workplace culture where a senior woman’s health in her 50s, 60s or 70s is treated as a retention question worth planning for, not something she’s expected to manage quietly on her own.

South African companies are having this conversation for the first time, not catching up on years of established practice elsewhere.

That means there’s nothing to unwind and no existing shape to widen later.

Building around postmenopause, the phase that lasts 30 to 40 years, from the very start costs no more than building around the decade everyone currently defaults to.

It’s also the only version that actually matches how long the issue lasts.

About Dr Juanri Jonck

Dr Juanri Jonck, MBChB, is a medical doctor specialising in aesthetic and regenerative medicine and co-founder of LifeLAB, a serum-led skincare range built on menopausal skin biology. She practises in Pretoria, South Africa.
    Let's do Biz